Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL3306696 | 1.00 | SLC34A1 (0.58) | — | |
| Phosphoric Acid SCHEMBL1742995 | 1.00 | SLC34A1 (0.58) | — | |
| Phosphoric Acid SCHEMBL733844 | 1.00 | SLC34A1 (0.58) | — | |
| Phosphoric Acid SCHEMBL4611532 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL166796 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL7871826 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL7871824 | 0.95 | SLC34A1 (0.54) | — | |
| Phosphoric Acid SCHEMBL21612686 | 0.95 | SLC34A1 (0.54) | — | |
| Phosphoric Acid SCHEMBL22116976 | 0.95 | SLC34A1 (0.54) | — | |
| Phosphoric Acid SCHEMBL5330837 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1013 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746857-A1 | PRODUCTION AND DELIVERY OF THERAPEUTIC NUCLEIC ACIDS PACKAGED IN YEAST EXTRACELLULAR VESICLES EMBEDDED IN BIOCOMPATIBLE IMPLANT MATRICES | Mercury Bio, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4709434-A1 | CALCIUM PHOSPHATE POWDER COMPOSITION | Biomimetic Innovations Limited (IE) | 2026-03-18 | — | — | EP | claimed |
| US-12575784-B2 | Devices and methods for the detection of intraoral acid exposure | KING'S COLLEGE LONDON (GB) | 2026-03-17 | — | — | US | claimed |
| US-12544482-B2 | Antipathogenic compositions | SERVICO GROUP OY (FI) | 2026-02-10 | — | — | US | claimed |
| US-12539351-B2 | Bone substitute composition | METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) | 2026-02-03 | — | — | US | claimed |
| WO-2025214820-A1 | COMPOUNDS FOR USE AS BONE REPLACEMENT AND/OR BONE REBUILDING MATERIAL | NOVAXOMX GMBH (DE) | 2025-10-16 | — | — | WO | claimed |
| EP-4631535-A1 | COMPOUNDS FOR USE AS BONE REPLACEMENT AND/OR BONE REBUILDING MATERIAL | novaxomx GmbH (DE) | 2025-10-15 | — | — | EP | claimed |
| EP-4168020-B1 | PLASMA-TREATED HYDROGEL COMPOSITIONS AND USES THEREOF | UNIV CATALUNYA POLITECNICA (ES) | 2025-10-15 | — | — | EP | claimed |
| US-20250249147-A1 | BIOMIMETIC NANO-COMPOSITE SCAFFOLD FOR ENHANCED BONE HEALING AND FRACTURE REPAIR | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2025-08-07 | — | — | US | claimed |
| US-20250179301-A1 | Process for producing a white UV-absorbing surface-reacted calcium carbonate doped with a titanium species, a white UV-absorbing surface-reacted calcium carbonate and use thereof | OMYA INTERNATIONAL AG (CH) | 2025-06-05 | — | — | US | claimed |
| WO-2005016616-A1 | METHODS FOR PREPARING MEDICAL IMPLANTS FROM CALCIUM PHOSPHATE CEMENT AND MEDICAL IMPLANTS | CALCITEC, INC. (US) | 2005-02-24 | — | — | WO | claimed |
| US-20050029701-A1 | Method for making a molded calcium phosphate article | CANA LAB CORPORATION (TW) | 2005-02-10 | — | — | US | claimed |
| US-20030216777-A1 | Method of enhancing healing of interfacial gap between bone and tendon or ligament | CALCITEC, INC. | 2003-11-20 | — | — | US | claimed |
| US-6648960-B1 | Heat treatment without using additives or sacrificing strength | CANA LAB CORPORATION (TW) | 2003-11-18 | — | — | US | claimed |
| EP-1235599-B1 | BRUSHITE HYDRAULIC CEMENT STABILIZED WITH A MAGNESIUM SALT | ROBERT MATHYS STIFTUNG (CH) | 2003-07-23 | — | — | EP | claimed |
| EP-0929225-B1 | METHOD OF PREPARING DOUGH | PILLSBURY CO (US) | 2001-12-12 | — | — | EP | claimed |
| EP-0929224-B1 | METHOD OF PREPARING DOUGH | PILLSBURY CO (US) | 2001-12-05 | — | — | EP | claimed |
| EP-0567373-B1 | Fluid hydrated ferrous sulfate and process for fluidizing polyhydrated metallic sulfates | SOCADOUR (FR) | 1997-03-19 | — | — | EP | claimed |
| US-5300297-A | Core containing biologically active substance coated with mixture of lecithin, acid soluble inorganic substance, fat or wax | AJINOMOTO CO., INC. (JP) | 1994-04-05 | — | — | US | claimed |
| EP-0350607-A2 | Use of calcium dihydrogen pyrophosphate as leavening acid in slow reacting leavening compositions and method for producing the same | Benckiser-Knapsack GmbH (DE) | 1990-01-17 | — | — | EP | claimed |